4 insiders bought €140k of shares over the last 90 days, the latest filed 07 Oct 2026.
Saniona AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Saniona AB logged 7 filings by 4 insiders.
No insider sold shares on the market over the period. Instead, the filings list 7 purchases totalling €195k, made by 4 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. John Haurum filed the largest purchase, €67k, on 7 October 2026, which represents 0.057% of the company's market value. On the buying side, the filings list 2 board members, 1 finance chief and 1 chief executive among the declarants.
Within a 30-day window, 4 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (7 October 2026) now reads 10 days. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19).
For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 7 filings here. Our records for Saniona AB go back to 2021, with 12 purchases and 2 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
19 of 19 declarations
Saniona AB is a biopharmaceutical company focused on developing treatments for central nervous system disorders and metabolic diseases. It is listed on the XSTO exchange.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 6 filings published between 28 August and 7 October 2026: 6 open-market purchases by insiders for €140k. Largest amounts: John Haurum (Styrelseordförande), purchases of €116k; johnny stilou (Ekonomichef/finanschef/finansdirektör), purchases of €10k; Jorgen Drejer (Vice VD), purchases of €9,178.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)